MyPerioPathsm and MyPerioIDsm PST
Used together, MyPerioPathsm® and MyPerioIDsm PST® salivary DNA diagnostic tests can help reduce patient incidence of periodontal disease by helping identify patients with and at risk. This is genetic testing for gum disease, performed with an easy saliva test.
According to the American Dental Association, an estimated 75% of all Americans over the age of 35 have some form of periodontal disease. Moreover, research conducted during the past 10 years has provided insight into the Perio / Systemic Connection and the link between chronic periodontal infections and heart disease, diabetes, stroke, and some forms of cancer.
OralDNA offers two DNA-Polymerase Chain Reaction (PCR) tests for periodontal disease diagnosis and genetic susceptibility: MyPerioPath detects the presence and quantity of specific bacteria associated with periodontal disease, while MyPerioIDsm PST provides a means of assessing an individual’s genetic risk for periodontal disease. The company also has an oral HPV test named OraRisksm HPV for use in assessing the risks associated with certain types of oral cancer.
Used together, the new salivary DNA diagnostic tests can help reduce patient incidence of periodontal disease. MyPerioPathsm provides early and accurate diagnosis of existing periodontal disease by identifying and measuring specific types of bacteria, while MyPerioIDsm PST assesses a patient’s genetic predisposition to developing periodontal disease well before physical symptoms occur.